Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 20, 2019

The chaos of serologic markers in interstitial pneumonia with autoimmune features can be corrected by the laboratory physician

La-He Jearn and Think-You Kim

Corresponding author: Think-You Kim, MD, Division of Diagnostic Immunology, Department of Laboratory Medicine, College of Medicine, Hanyang University, 222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763, Republic of Korea, Phone: +82-2-2290-8978, Fax: +82-2-2290-9193

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


1. Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015;46:976–87.10.1183/13993003.00150-2015Search in Google Scholar PubMed

2. Collins BF, Spiekerman CF, Shaw MA, Ho LA, Hayes J, Spada CA, et al. Idiopathic interstitial pneumonia associated with autoantibodies: a large case series followed over 1 year. Chest 2017;152:103–12.10.1016/j.chest.2017.03.004Search in Google Scholar PubMed PubMed Central

3. Jearn LH, Kim TY. Autoantibodies are already found in connective tissue disease-associated interstitial lung disease [Letter]. Chest 2016;150:753–5.10.1016/j.chest.2016.06.036Search in Google Scholar PubMed

4. Chan EK, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PL, et al. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014–2015. Front Immunol 2015;6:412.10.3389/fimmu.2015.00412Search in Google Scholar PubMed PubMed Central

5. von Mühlen CA, Fritzler MJ, Chan EK. Clinical and laboratory evaluation of systemic rheumatic diseases. In: McPherson RA, Pincus MR, editors. HENRY’s Clinical Diagnosis and Managementby Laboratory Methods, 23rd ed. St. Louis, MO: Elsevier Inc., 2017:993–1015.Search in Google Scholar

6. Aggarwal R, Dhillon N, Fertig N, Koontz D, Qi Z, Oddis CV. A negative antinuclear antibody does not indicate autoantibody negativity in myositis: role of anticytoplasmic antibody as a screening test for antisynthetase syndrome. J Rheumatol 2017;44:223–9.10.3899/jrheum.160618Search in Google Scholar PubMed

7. Bradwell AR. Immunofluorescent antinuclear antibody tests. In: Rose NR, Hamilton RG, Detrick B, editors. Manual of Clinical Laboratory Immunology, 6th ed. Washington, DC: ASM Press, 2002:922–32.Search in Google Scholar

8. Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73:17–23.10.1136/annrheumdis-2013-203863Search in Google Scholar PubMed

9. Jearn LH, Kim TY. Level of anticitrullinated peptide/protein antibody is not associated with lung diseases in rheumatoid arthritis [Letter]. J Rheumatol 2012;39:1493–4.10.3899/jrheum.111478Search in Google Scholar PubMed

10. Lee DS, Lee CB, Koh HK, Moon DS, Lee JY, Lee KS, et al. The utility of immunological markers and pulmonary function test in the early diagnosis of pulmonary involvement in the patients with rheumatoid arthritis. Tuberc Respir Dis 1995;42:878–87.10.4046/trd.1995.42.6.878Search in Google Scholar

Received: 2019-06-27
Accepted: 2019-08-25
Published Online: 2019-09-20
Published in Print: 2020-02-25

©2020 Walter de Gruyter GmbH, Berlin/Boston